Phase-1 Becomes Authorized Affymetrix Service Provider

Phase-1 Molecular Toxicology of Santa Fe, NM, last week joined a growing list of companies that are authorized service providers for Affymetrix.

Phase-1, which focuses on toxicogenomics, will provide scanning and analysis of GeneChip-brand microarrays in addition to the cDNA microarray services it provides. The eight-year-old company emerged from Chapter 11 bankruptcy proceedings in December with a staff of 15, according to an April report in the New Mexico Business Weekly.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.